BDBM221688 US10568884, Cpd 9::US12076320, Example L-5-S::US9314464, 9::US9593100, Compound 9::USRE49556, Compound 9

SMILES COC(=O)N[C@@H](C)CNc1nccc(n1)-c1cn(nc1-c1cc(Cl)cc(NS(C)(=O)=O)c1F)C(C)C

InChI Key InChIKey=CMJCXYNUCSMDBY-UHFFFAOYSA-N

Data  26 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 26 hits for monomerid = 221688   

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.64nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 12nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.74nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 7.41nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.58nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.66nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.77nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.14nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.26nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.22nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.43nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.36nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.57nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 0.300nMpH: 7.5 T: 2°CAssay Description:B-Raf (V600E; 4 μM) and biotinylated Mek (kinase dead; 10 nM) were combined at 2× final concentrations in assay buffer (50 mM Tris, pH 7.5, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.31nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.49nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 4.98nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.49nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.95nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 0.300nMAssay Description:B-Raf (V600E; 4 pM) and biotinylated Mek (kinase dead; 10 nM) were combined at 2× final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 4nMAssay Description:Inhibition of BRAF V600E mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 4nMAssay Description:Inhibition of BRAF (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 0.300nMAssay Description:The B-Raf kinase activity reaction was started by the addition of 10 μl piper well of 2×ATP (10 μM) diluted in assay buffer. After 3 hours,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/30/2020
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of BRAF V600E mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 0.300nMAssay Description:B-Raf (V600E; 4 pM) and biotinylated Mek (kinase dead; 10 nM) were combined at 2× final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 0.300nMAssay Description:B-Raf (V600E; 4 pM) and biotinylated Mek (kinase dead; 10 nM) were combined at 2× final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2019
Entry Details
Go to US Patent